{"transactions":[{"id":2374907,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-02-24T19:05:03.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On February 17, 2022, Mr. Humphrey was granted an option (the \"Stock Option\") to purchase 80,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with an exercise price of $1.40. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 17, 2022 and the remainder in equal installments monthly for the thirty-six months thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 17, 2022, Mr. Humphrey was granted an option (the \"Stock Option\") to purchase 80,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with an exercise price of $1.40. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 17, 2022 and the remainder in equal installments monthly for the thirty-six months thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 17, 2022, Mr. Humphrey was granted an option (the \"Stock Option\") to purchase 80,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.0001 per share, with an exercise price of $1.40. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 17, 2022 and the remainder in equal installments monthly for the thirty-six months thereafter."}],"balance_after":80000,"derivative":{"exercise_price":1.4,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-22-005445","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708720/000149315222005445/ownership.xml","form_type":"4"}},{"id":2411727,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-02-04T15:15:01.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":275000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On February 4, 2022, Mr. Humphrey was granted an option (the \"Stock Option\") to purchase 275,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.01 per share, with an exercise price of $3.13. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 11, 2021 and the remainder in equal installments monthly for the thirty-six months thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 4, 2022, Mr. Humphrey was granted an option (the \"Stock Option\") to purchase 275,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.01 per share, with an exercise price of $3.13. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 11, 2021 and the remainder in equal installments monthly for the thirty-six months thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 4, 2022, Mr. Humphrey was granted an option (the \"Stock Option\") to purchase 275,000 shares of common stock of Ensysce Biosciences, Inc. (the \"Company\"), par value $0.01 per share, with an exercise price of $3.13. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 11, 2021 and the remainder in equal installments monthly for the thirty-six months thereafter."}],"balance_after":275000,"derivative":{"exercise_price":3.13,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001493152-22-003204","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708720/000149315222003204/ownership.xml","form_type":"4"}},{"id":2644946,"issuer":{"id":8108,"kind":"organization","name":"Ensysce Biosciences, Inc."},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-02T19:15:02.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 30, 2021, pursuant to that certain Agreement and Plan of Merger, dated January 31, 2021, among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the \"Issuer\"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer (\"Merger Sub\"), and Ensysce Biosciences, Inc., a Delaware corporation (\"Ensysce\"), Merger Sub merged with and into Ensysce (the \"Merger\"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Upon completion of the Merger, the Reporting Person received a grant of 50,000 restricted stock units, which, subject generally to the Reporting Person's continued employment through each such date would vest as to 20,000 restricted stock units on December 15, 2021, an additional 15,000 restricted stock units on December 15, 2022, and an additional 15,000 restricted stock units on December 15, 2023."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-21-016123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708720/000149315221016123/ownership.xml","form_type":"4"}},{"id":3776699,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"V.P. & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T18:06:40.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":90800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":90800},"source":{"system":"sec-edgar","filing":"0001209191-18-056995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118056995/doc4.xml","form_type":"4"}},{"id":3776698,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"V.P. & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T18:06:40.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.02,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-18-056995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118056995/doc4.xml","form_type":"4"}},{"id":3776697,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"V.P. & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T18:06:40.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":56000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":0.87,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001209191-18-056995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118056995/doc4.xml","form_type":"4"}},{"id":3776696,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"V.P. & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-02T18:06:40.000Z","date":"2018-11-02","kind":"other","acquired":false,"shares":432810,"price":1.5,"value":649215.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 46,173 shares of Common Stock that were acquired by the Reporting Person on 8/31/18 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 16, 2018, among the Issuer, Firmenich Incorporated, a Delaware corporation (\"Parent\"), and Sentry Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\") in exchange for a cash consideration of $1.50 per share, without interest, subject to any applicable withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-056995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118056995/doc4.xml","form_type":"4"}},{"id":3986542,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"officer":true,"officer_title":"Vice President, Finance"}}],"security":"Stock option (right to buy)","published_at":"2018-03-21T18:52:06.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":90800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was granted on 03/15/2018.  The option vests over four years with 1/4 of the total number of shares subject to the option vesting on the first anniversary of the date of grant and 1/48th of the total number of shares subject to the option vesting monthly thereafter, until fully vested on 03/15/2022."}],"balance_after":90800,"derivative":{"exercise_price":1.05,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":90800},"source":{"system":"sec-edgar","filing":"0001437749-18-005185","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774918005185/rdgdoc.xml","form_type":"4"}},{"id":3986541,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":130024,"kind":"person","name":"Humphrey David Carl","position":1,"cik":"0001708720","reported_name":"Humphrey David Carl","relationship":{"officer":true,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2018-03-21T18:52:06.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":36457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Although not required, the Reporting Person has elected to report 36,457 shares of Common Stock that were acquired by the Reporting Person on 2/28/18 pursuant to the Issuer's Employee Stock Purchase Plan"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 85,765 shares held by spouse."}],"balance_after":386637,"source":{"system":"sec-edgar","filing":"0001437749-18-005185","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774918005185/rdgdoc.xml","form_type":"4"}}]}